<DOC>
	<DOCNO>NCT01755858</DOCNO>
	<brief_summary>The primary objective trial ass effect Bendavia renal blood flow renal function atherosclerotic renal artery stenosis ( ARAS ) , compare placebo patient ARAS receive one dose study drug infuse 30 minute 3 hour percutaneous transluminal angioplasty renal artery ( PTRA ) .</brief_summary>
	<brief_title>Study Assess Effects Intravenous Bendavia Patients Undergoing Percutaneous Transluminal Angioplasty Renal Artery ( PTRA )</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Reperfusion Injury</mesh_term>
	<mesh_term>Renal Artery Obstruction</mesh_term>
	<mesh_term>Hypertension , Renovascular</mesh_term>
	<criteria>≥40 ≤80 year old . Patients hypertension ( systolic blood pressure [ BP ] &gt; 155 mm Hg ) and/or require 2 antihypertensive medication : restriction place antihypertensive agent , although loop diuretic temporarily change dilute site agent ( eg , hydrochlorothiazide , indapamide , metolazone ) prior blood oxygen leveldependent magnetic resonance imaging ( BOLDMRI ) study perform trial , unless , judgment Investigator , change represent hazard patient . ARAS patient identify base upon radiologic clinical criterion suggestive renovascular hypertension and/or hemodynamically significant renovascular disease &gt; 60 % lumen occlusion ( determined quantitative compute tomography angiography Doppler ultrasound velocity &gt; 200 cm/sec ) . Have estimate glomerular filtration rate ≥15 ml/min/1.73 m2 calculate use Modification Diet Renal Disease ( MDRD ) formula . Have contraindication angiography severe contrast allergy . Have contraindication noncontrast magnetic resonance evaluation pacemaker magnetically active metal fragment . Able comply protocol . Women childbearing age must : Have negative pregnancy serum human chorionic gonadotropin test prior receive study drug . Agree use two form contraception 3 month follow receipt study drug . Men sexually active able father child , must agree use one birth control method list entire study least 2 month receive study drug : Barrier method ( condom diaphragm ) use spermicide . Hormonal method use partner , birth control pill , patch , injection , vaginal ring , implant . Intrauterine device ( IUD ) use partner . Abstinence ( sex ) . Competent able provide write informed consent Advanced chronic kidney disease define either Stage 5 endstage renal disease require dialysis . Have clinically significant abnormality laboratory result would , opinion investigator , compromise safety patient include evidence diabetic ketoacidosis , paraproteinemia , triglycerides 600 mg/dL . Clinically significant medical condition within six month administration Bendavia ( e.g. , cancer , stroke , myocardial infarction , active angina , congestive heart failure ) would , opinion investigator , compromise safety patient . Have receive investigational drug within thirty ( 30 ) day baseline . Have serum sodium &lt; 135 mmol/L day , prior , PTRA . Are pregnant breast feeding .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>elamipretide</keyword>
</DOC>